Cardiora Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Cardiora General Information

Description

Developer of an oral drug designed to prevent heart failure. The company's oral drug is a compound that has functional outcomes with ensured safety, enabling patients to avail improved quality of life and reduced hospital re-admission rates.

Contact Information

Website
www.cardiora.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Level 9, 31 Queen Street
  • Melbourne, Victoria 3000
  • Australia
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
LOHAS & Wellness, Life Sciences
Corporate Office
  • Level 9, 31 Queen Street
  • Melbourne, Victoria 3000
  • Australia

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cardiora Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 02-Apr-2021 Completed Out of Business
1. Later Stage VC 04-Dec-2020 Completed Generating Revenue
To view Cardiora’s complete valuation and funding history, request access »

Cardiora Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
PARTICIPATIVE PREFERENCE SHARES
To view Cardiora’s complete cap table history, request access »

Cardiora Patents

  • 5

    Total Documents Applications and Grants

  • Total Patents Families

  • 3

    Granted

  • Pending

  • Expiring in next 12 mo

Cardiora Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3236963-B1 Method of treatment Active 22-Dec-2014
EP-3236963-A1 Method of treatment Active 22-Dec-2014
EP-3236963-A4 Method of treatment Active 22-Dec-2014
EP-2744496-A1 Controlled-release formulation Inactive 16-Aug-2011
EP-2744496-A4 Controlled-release formulation Inactive 16-Aug-2011 A61K9/2866
To view Cardiora’s complete patent history, request access »

Ready to get started?

Request a free trial

Cardiora FAQs

  • When was Cardiora founded?

    Cardiora was founded in 2015.

  • Where is Cardiora headquartered?

    Cardiora is headquartered in Melbourne, Australia.

  • What industry is Cardiora in?

    Cardiora’s primary industry is Drug Discovery.

  • Is Cardiora a private or public company?

    Cardiora is a Private company.

  • What is Cardiora’s current revenue?

    The current revenue for Cardiora is .

  • How much funding has Cardiora raised over time?

    Cardiora has raised $4.19M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »